BioCryst Pharmaceuticals, Inc.
BCRX
$8.80
$0.222.56%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -13.23% | 29.07% | -18.14% | -11.88% | -8.03% |
| Total Receivables | 2.30% | 16.96% | 0.16% | -2.37% | 18.12% |
| Inventory | 10.87% | 3.17% | 3.73% | -26.61% | -15.01% |
| Prepaid Expenses | 11.24% | 4.12% | 31.58% | -12.47% | 4.18% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 324.88% | -99.32% | 0.30% | 10,093.13% | 38.57% |
| Total Current Assets | -7.60% | 13.68% | -10.74% | -2.81% | -2.84% |
|
|
|||||
| Total Current Assets | -7.60% | 13.68% | -10.74% | -2.81% | -2.84% |
| Net Property, Plant & Equipment | 21.06% | -1.30% | -3.83% | 2.19% | -1.06% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 61.40% | -6.83% | 11.23% | -4.42% | 5.66% |
| Total Assets | -9.55% | 15.17% | -2.35% | -4.76% | -2.12% |
|
|
|||||
| Total Accounts Payable | -30.76% | 184.28% | -35.18% | -14.53% | -13.70% |
| Total Accrued Expenses | -5.55% | 6.43% | 10.89% | 15.63% | -18.23% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 8.30% | 1.56% | 4.56% | 1.55% | 4.86% |
| Total Finance Division Other Current Liabilities | 57.35% | -47.99% | 11.45% | -- | -- |
| Total Other Current Liabilities | 57.35% | -47.99% | 11.45% | -- | -- |
| Total Current Liabilities | -0.34% | 3.06% | 7.38% | 26.67% | -12.80% |
|
|
|||||
| Total Current Liabilities | -0.34% | 3.06% | 7.38% | 26.67% | -12.80% |
| Long-Term Debt | 87.81% | -32.56% | -8.28% | -11.69% | -1.75% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 22.80% | -1.52% | -3.47% | 4.35% | 0.45% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -3.96% | -- | -- |
| Total Liabilities | 60.88% | -24.09% | -5.06% | -5.71% | -3.56% |
|
|
|||||
| Common Stock & APIC | 20.73% | 1.76% | 1.59% | 1.88% | 1.84% |
| Retained Earnings | -47.92% | 14.03% | 0.73% | 0.29% | 0.00% |
| Treasury Stock & Other | -1,068.42% | -96.67% | -30.74% | 45.41% | 22.91% |
| Total Common Equity | -364.82% | 69.28% | 7.99% | 6.71% | 5.04% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -364.82% | 69.28% | 7.99% | 6.71% | 5.04% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -364.82% | 69.28% | 7.99% | 6.71% | 5.04% |
|
|
|||||